Global Deutenzalutamide Soft Capsules Supply, Demand and Key Producers, 2026-2032
The global Deutenzalutamide Soft Capsules market size is expected to reach $ 375 million by 2032, rising at a market growth of 12.5% CAGR during the forecast period (2026-2032).
Deutenzalutamide soft capsules are a novel oral androgen receptor inhibitor modified by deuteration. By specifically binding to the androgen receptor and blocking its signal transduction, they inhibit the proliferation and survival of tumor cells, and are mainly used for the treatment of metastatic castration?resistant prostate cancer. As a deuterated improved drug based on enzalutamide, its structural optimization enhances metabolic stability, prolongs its duration of action in vivo and improves safety. Featuring favorable oral absorption and convenient administration, it provides a better?tolerated therapeutic option for patients with advanced prostate cancer and holds important clinical value in the field of genitourinary oncology.In 2025, global Deutenzalutamide soft capsules production reached approximately 120,000 units.
Deutenzalutamide soft capsules, as the first deuterated androgen receptor inhibitor approved in China, have filled the gap in domestic innovative drugs for the targeted treatment of metastatic castration?resistant prostate cancer. Relying on deuteration technology, they have achieved remarkable improvements in metabolic stability and safety, showing clear clinical advantages in reducing central nervous system adverse reactions and enhancing tolerability in elderly patients.
Its market positioning focuses on differentiated therapeutic needs, mainly serving patients intolerant to or with unsatisfactory efficacy from existing medications, thus forming misplaced competition with the original enzalutamide and domestic generics and avoiding fierce price wars.
With the rising incidence of prostate cancer, accelerating population aging, and official inclusion in the medical insurance catalogue in China, the drug?s market accessibility and growth potential have been greatly enhanced, making it an important force for domestic innovative drugs to replace foreign products and seize the high?end genitourinary oncology market.
In the future, its commercialization will be promoted through the coordination of medical insurance reimbursement, hospital access, and academic promotion. Relying on its unique clinical value and status as a domestic innovative drug, it will continue to expand its share in the rapidly growing prostate cancer drug market.
This report studies the global Deutenzalutamide Soft Capsules production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Deutenzalutamide Soft Capsules and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Deutenzalutamide Soft Capsules that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Deutenzalutamide Soft Capsules total production and demand, 2021-2032, (Units)
Global Deutenzalutamide Soft Capsules total production value, 2021-2032, (USD Million)
Global Deutenzalutamide Soft Capsules production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Deutenzalutamide Soft Capsules consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Deutenzalutamide Soft Capsules domestic production, consumption, key domestic manufacturers and share
Global Deutenzalutamide Soft Capsules production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Deutenzalutamide Soft Capsules production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Deutenzalutamide Soft Capsules production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Deutenzalutamide Soft Capsules market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hinovapharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Deutenzalutamide Soft Capsules market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Deutenzalutamide Soft Capsules Market, By Region:
1. How big is the global Deutenzalutamide Soft Capsules market?
2. What is the demand of the global Deutenzalutamide Soft Capsules market?
3. What is the year over year growth of the global Deutenzalutamide Soft Capsules market?
4. What is the production and production value of the global Deutenzalutamide Soft Capsules market?
5. Who are the key producers in the global Deutenzalutamide Soft Capsules market?
6. What are the growth factors driving the market demand?
Deutenzalutamide soft capsules are a novel oral androgen receptor inhibitor modified by deuteration. By specifically binding to the androgen receptor and blocking its signal transduction, they inhibit the proliferation and survival of tumor cells, and are mainly used for the treatment of metastatic castration?resistant prostate cancer. As a deuterated improved drug based on enzalutamide, its structural optimization enhances metabolic stability, prolongs its duration of action in vivo and improves safety. Featuring favorable oral absorption and convenient administration, it provides a better?tolerated therapeutic option for patients with advanced prostate cancer and holds important clinical value in the field of genitourinary oncology.In 2025, global Deutenzalutamide soft capsules production reached approximately 120,000 units.
Deutenzalutamide soft capsules, as the first deuterated androgen receptor inhibitor approved in China, have filled the gap in domestic innovative drugs for the targeted treatment of metastatic castration?resistant prostate cancer. Relying on deuteration technology, they have achieved remarkable improvements in metabolic stability and safety, showing clear clinical advantages in reducing central nervous system adverse reactions and enhancing tolerability in elderly patients.
Its market positioning focuses on differentiated therapeutic needs, mainly serving patients intolerant to or with unsatisfactory efficacy from existing medications, thus forming misplaced competition with the original enzalutamide and domestic generics and avoiding fierce price wars.
With the rising incidence of prostate cancer, accelerating population aging, and official inclusion in the medical insurance catalogue in China, the drug?s market accessibility and growth potential have been greatly enhanced, making it an important force for domestic innovative drugs to replace foreign products and seize the high?end genitourinary oncology market.
In the future, its commercialization will be promoted through the coordination of medical insurance reimbursement, hospital access, and academic promotion. Relying on its unique clinical value and status as a domestic innovative drug, it will continue to expand its share in the rapidly growing prostate cancer drug market.
This report studies the global Deutenzalutamide Soft Capsules production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Deutenzalutamide Soft Capsules and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Deutenzalutamide Soft Capsules that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Deutenzalutamide Soft Capsules total production and demand, 2021-2032, (Units)
Global Deutenzalutamide Soft Capsules total production value, 2021-2032, (USD Million)
Global Deutenzalutamide Soft Capsules production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Deutenzalutamide Soft Capsules consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Deutenzalutamide Soft Capsules domestic production, consumption, key domestic manufacturers and share
Global Deutenzalutamide Soft Capsules production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Deutenzalutamide Soft Capsules production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Deutenzalutamide Soft Capsules production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Deutenzalutamide Soft Capsules market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hinovapharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Deutenzalutamide Soft Capsules market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Deutenzalutamide Soft Capsules Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- 28 Capsules Per Box
- 112 Capsules Per Bottle
- Deuteroenzalutamide in combination with Androgen Synthesis Inhibitors
- Deuteroenzalutamide in combination with Hormonal Antineoplastic Drugs
- Innovator
- Generic
- Hospital
- Retail
- Online
- Metastatic Castration-Resistant Prostate Cancer
- Non-Metastatic Castration-Resistant Prostate Cancer
- Metastatic Hormone-Sensitive Prostate Cancer
- Others
- Hinovapharma
1. How big is the global Deutenzalutamide Soft Capsules market?
2. What is the demand of the global Deutenzalutamide Soft Capsules market?
3. What is the year over year growth of the global Deutenzalutamide Soft Capsules market?
4. What is the production and production value of the global Deutenzalutamide Soft Capsules market?
5. Who are the key producers in the global Deutenzalutamide Soft Capsules market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Deutenzalutamide Soft Capsules Introduction
1.2 World Deutenzalutamide Soft Capsules Supply & Forecast
1.2.1 World Deutenzalutamide Soft Capsules Production Value (2021 & 2025 & 2032)
1.2.2 World Deutenzalutamide Soft Capsules Production (2021-2032)
1.2.3 World Deutenzalutamide Soft Capsules Pricing Trends (2021-2032)
1.3 World Deutenzalutamide Soft Capsules Production by Region (Based on Production Site)
1.3.1 World Deutenzalutamide Soft Capsules Production Value by Region (2021-2032)
1.3.2 World Deutenzalutamide Soft Capsules Production by Region (2021-2032)
1.3.3 World Deutenzalutamide Soft Capsules Average Price by Region (2021-2032)
1.3.4 China Deutenzalutamide Soft Capsules Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Deutenzalutamide Soft Capsules Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Deutenzalutamide Soft Capsules Major Market Trends
2 DEMAND SUMMARY
2.1 World Deutenzalutamide Soft Capsules Demand (2021-2032)
2.2 World Deutenzalutamide Soft Capsules Consumption by Region
2.2.1 World Deutenzalutamide Soft Capsules Consumption by Region (2021-2026)
2.2.2 World Deutenzalutamide Soft Capsules Consumption Forecast by Region (2027-2032)
2.3 United States Deutenzalutamide Soft Capsules Consumption (2021-2032)
2.4 China Deutenzalutamide Soft Capsules Consumption (2021-2032)
2.5 Europe Deutenzalutamide Soft Capsules Consumption (2021-2032)
2.6 Japan Deutenzalutamide Soft Capsules Consumption (2021-2032)
2.7 South Korea Deutenzalutamide Soft Capsules Consumption (2021-2032)
2.8 ASEAN Deutenzalutamide Soft Capsules Consumption (2021-2032)
2.9 India Deutenzalutamide Soft Capsules Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Deutenzalutamide Soft Capsules Production Value by Manufacturer (2021-2026)
3.2 World Deutenzalutamide Soft Capsules Production by Manufacturer (2021-2026)
3.3 World Deutenzalutamide Soft Capsules Average Price by Manufacturer (2021-2026)
3.4 Deutenzalutamide Soft Capsules Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Deutenzalutamide Soft Capsules Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Deutenzalutamide Soft Capsules in 2025
3.5.3 Global Concentration Ratios (CR8) for Deutenzalutamide Soft Capsules in 2025
3.6 Deutenzalutamide Soft Capsules Market: Overall Company Footprint Analysis
3.6.1 Deutenzalutamide Soft Capsules Market: Region Footprint
3.6.2 Deutenzalutamide Soft Capsules Market: Company Product Type Footprint
3.6.3 Deutenzalutamide Soft Capsules Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Deutenzalutamide Soft Capsules Production Value Comparison
4.1.1 United States VS China: Deutenzalutamide Soft Capsules Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Deutenzalutamide Soft Capsules Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Deutenzalutamide Soft Capsules Production Comparison
4.2.1 United States VS China: Deutenzalutamide Soft Capsules Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Deutenzalutamide Soft Capsules Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Deutenzalutamide Soft Capsules Consumption Comparison
4.3.1 United States VS China: Deutenzalutamide Soft Capsules Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Deutenzalutamide Soft Capsules Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Deutenzalutamide Soft Capsules Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Deutenzalutamide Soft Capsules Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Deutenzalutamide Soft Capsules Production Value (2021-2026)
4.4.3 United States Based Manufacturers Deutenzalutamide Soft Capsules Production (2021-2026)
4.5 China Based Deutenzalutamide Soft Capsules Manufacturers and Market Share
4.5.1 China Based Deutenzalutamide Soft Capsules Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Deutenzalutamide Soft Capsules Production Value (2021-2026)
4.5.3 China Based Manufacturers Deutenzalutamide Soft Capsules Production (2021-2026)
4.6 Rest of World Based Deutenzalutamide Soft Capsules Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Deutenzalutamide Soft Capsules Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Deutenzalutamide Soft Capsules Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Deutenzalutamide Soft Capsules Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Deutenzalutamide Soft Capsules Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 28 Capsules Per Box
5.2.2 112 Capsules Per Bottle
5.3 Market Segment by Type
5.3.1 World Deutenzalutamide Soft Capsules Production by Type (2021-2032)
5.3.2 World Deutenzalutamide Soft Capsules Production Value by Type (2021-2032)
5.3.3 World Deutenzalutamide Soft Capsules Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY COMBINED MEDICATION
6.1 World Deutenzalutamide Soft Capsules Market Size Overview by Combined medication: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Combined medication
6.2.1 Deuteroenzalutamide in combination with Androgen Synthesis Inhibitors
6.2.2 Deuteroenzalutamide in combination with Hormonal Antineoplastic Drugs
6.3 Market Segment by Combined medication
6.3.1 World Deutenzalutamide Soft Capsules Production by Combined medication (2021-2032)
6.3.2 World Deutenzalutamide Soft Capsules Production Value by Combined medication (2021-2032)
6.3.3 World Deutenzalutamide Soft Capsules Average Price by Combined medication (2021-2032)
7 MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
7.1 World Deutenzalutamide Soft Capsules Market Size Overview by Production Technology: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Production Technology
7.2.1 Innovator
7.2.2 Generic
7.3 Market Segment by Production Technology
7.3.1 World Deutenzalutamide Soft Capsules Production by Production Technology (2021-2032)
7.3.2 World Deutenzalutamide Soft Capsules Production Value by Production Technology (2021-2032)
7.3.3 World Deutenzalutamide Soft Capsules Average Price by Production Technology (2021-2032)
8 MARKET ANALYSIS BY SALES CHANNELS
8.1 World Deutenzalutamide Soft Capsules Market Size Overview by Sales Channels: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Sales Channels
8.2.1 Hospital
8.2.2 Retail
8.2.3 Online
8.3 Market Segment by Sales Channels
8.3.1 World Deutenzalutamide Soft Capsules Production by Sales Channels (2021-2032)
8.3.2 World Deutenzalutamide Soft Capsules Production Value by Sales Channels (2021-2032)
8.3.3 World Deutenzalutamide Soft Capsules Average Price by Sales Channels (2021-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World Deutenzalutamide Soft Capsules Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Metastatic Castration-Resistant Prostate Cancer
9.2.2 Non-Metastatic Castration-Resistant Prostate Cancer
9.2.3 Metastatic Hormone-Sensitive Prostate Cancer
9.2.4 Others
9.3 Market Segment by Application
9.3.1 World Deutenzalutamide Soft Capsules Production by Application (2021-2032)
9.3.2 World Deutenzalutamide Soft Capsules Production Value by Application (2021-2032)
9.3.3 World Deutenzalutamide Soft Capsules Average Price by Application (2021-2032)
10 COMPANY PROFILES
10.1 Hinovapharma
10.1.1 Hinovapharma Details
10.1.2 Hinovapharma Major Business
10.1.3 Hinovapharma Deutenzalutamide Soft Capsules Product and Services
10.1.4 Hinovapharma Deutenzalutamide Soft Capsules Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.1.5 Hinovapharma Recent Developments/Updates
10.1.6 Hinovapharma Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 Deutenzalutamide Soft Capsules Industry Chain
11.2 Deutenzalutamide Soft Capsules Upstream Analysis
11.2.1 Deutenzalutamide Soft Capsules Core Raw Materials
11.2.2 Main Manufacturers of Deutenzalutamide Soft Capsules Core Raw Materials
11.3 Midstream Analysis
11.4 Downstream Analysis
11.5 Deutenzalutamide Soft Capsules Production Mode
11.6 Deutenzalutamide Soft Capsules Procurement Model
11.7 Deutenzalutamide Soft Capsules Industry Sales Model and Sales Channels
11.7.1 Deutenzalutamide Soft Capsules Sales Model
11.7.2 Deutenzalutamide Soft Capsules Typical Distributors
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
1.1 Deutenzalutamide Soft Capsules Introduction
1.2 World Deutenzalutamide Soft Capsules Supply & Forecast
1.2.1 World Deutenzalutamide Soft Capsules Production Value (2021 & 2025 & 2032)
1.2.2 World Deutenzalutamide Soft Capsules Production (2021-2032)
1.2.3 World Deutenzalutamide Soft Capsules Pricing Trends (2021-2032)
1.3 World Deutenzalutamide Soft Capsules Production by Region (Based on Production Site)
1.3.1 World Deutenzalutamide Soft Capsules Production Value by Region (2021-2032)
1.3.2 World Deutenzalutamide Soft Capsules Production by Region (2021-2032)
1.3.3 World Deutenzalutamide Soft Capsules Average Price by Region (2021-2032)
1.3.4 China Deutenzalutamide Soft Capsules Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Deutenzalutamide Soft Capsules Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Deutenzalutamide Soft Capsules Major Market Trends
2 DEMAND SUMMARY
2.1 World Deutenzalutamide Soft Capsules Demand (2021-2032)
2.2 World Deutenzalutamide Soft Capsules Consumption by Region
2.2.1 World Deutenzalutamide Soft Capsules Consumption by Region (2021-2026)
2.2.2 World Deutenzalutamide Soft Capsules Consumption Forecast by Region (2027-2032)
2.3 United States Deutenzalutamide Soft Capsules Consumption (2021-2032)
2.4 China Deutenzalutamide Soft Capsules Consumption (2021-2032)
2.5 Europe Deutenzalutamide Soft Capsules Consumption (2021-2032)
2.6 Japan Deutenzalutamide Soft Capsules Consumption (2021-2032)
2.7 South Korea Deutenzalutamide Soft Capsules Consumption (2021-2032)
2.8 ASEAN Deutenzalutamide Soft Capsules Consumption (2021-2032)
2.9 India Deutenzalutamide Soft Capsules Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Deutenzalutamide Soft Capsules Production Value by Manufacturer (2021-2026)
3.2 World Deutenzalutamide Soft Capsules Production by Manufacturer (2021-2026)
3.3 World Deutenzalutamide Soft Capsules Average Price by Manufacturer (2021-2026)
3.4 Deutenzalutamide Soft Capsules Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Deutenzalutamide Soft Capsules Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Deutenzalutamide Soft Capsules in 2025
3.5.3 Global Concentration Ratios (CR8) for Deutenzalutamide Soft Capsules in 2025
3.6 Deutenzalutamide Soft Capsules Market: Overall Company Footprint Analysis
3.6.1 Deutenzalutamide Soft Capsules Market: Region Footprint
3.6.2 Deutenzalutamide Soft Capsules Market: Company Product Type Footprint
3.6.3 Deutenzalutamide Soft Capsules Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Deutenzalutamide Soft Capsules Production Value Comparison
4.1.1 United States VS China: Deutenzalutamide Soft Capsules Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Deutenzalutamide Soft Capsules Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Deutenzalutamide Soft Capsules Production Comparison
4.2.1 United States VS China: Deutenzalutamide Soft Capsules Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Deutenzalutamide Soft Capsules Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Deutenzalutamide Soft Capsules Consumption Comparison
4.3.1 United States VS China: Deutenzalutamide Soft Capsules Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Deutenzalutamide Soft Capsules Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Deutenzalutamide Soft Capsules Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Deutenzalutamide Soft Capsules Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Deutenzalutamide Soft Capsules Production Value (2021-2026)
4.4.3 United States Based Manufacturers Deutenzalutamide Soft Capsules Production (2021-2026)
4.5 China Based Deutenzalutamide Soft Capsules Manufacturers and Market Share
4.5.1 China Based Deutenzalutamide Soft Capsules Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Deutenzalutamide Soft Capsules Production Value (2021-2026)
4.5.3 China Based Manufacturers Deutenzalutamide Soft Capsules Production (2021-2026)
4.6 Rest of World Based Deutenzalutamide Soft Capsules Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Deutenzalutamide Soft Capsules Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Deutenzalutamide Soft Capsules Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Deutenzalutamide Soft Capsules Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Deutenzalutamide Soft Capsules Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 28 Capsules Per Box
5.2.2 112 Capsules Per Bottle
5.3 Market Segment by Type
5.3.1 World Deutenzalutamide Soft Capsules Production by Type (2021-2032)
5.3.2 World Deutenzalutamide Soft Capsules Production Value by Type (2021-2032)
5.3.3 World Deutenzalutamide Soft Capsules Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY COMBINED MEDICATION
6.1 World Deutenzalutamide Soft Capsules Market Size Overview by Combined medication: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Combined medication
6.2.1 Deuteroenzalutamide in combination with Androgen Synthesis Inhibitors
6.2.2 Deuteroenzalutamide in combination with Hormonal Antineoplastic Drugs
6.3 Market Segment by Combined medication
6.3.1 World Deutenzalutamide Soft Capsules Production by Combined medication (2021-2032)
6.3.2 World Deutenzalutamide Soft Capsules Production Value by Combined medication (2021-2032)
6.3.3 World Deutenzalutamide Soft Capsules Average Price by Combined medication (2021-2032)
7 MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
7.1 World Deutenzalutamide Soft Capsules Market Size Overview by Production Technology: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Production Technology
7.2.1 Innovator
7.2.2 Generic
7.3 Market Segment by Production Technology
7.3.1 World Deutenzalutamide Soft Capsules Production by Production Technology (2021-2032)
7.3.2 World Deutenzalutamide Soft Capsules Production Value by Production Technology (2021-2032)
7.3.3 World Deutenzalutamide Soft Capsules Average Price by Production Technology (2021-2032)
8 MARKET ANALYSIS BY SALES CHANNELS
8.1 World Deutenzalutamide Soft Capsules Market Size Overview by Sales Channels: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Sales Channels
8.2.1 Hospital
8.2.2 Retail
8.2.3 Online
8.3 Market Segment by Sales Channels
8.3.1 World Deutenzalutamide Soft Capsules Production by Sales Channels (2021-2032)
8.3.2 World Deutenzalutamide Soft Capsules Production Value by Sales Channels (2021-2032)
8.3.3 World Deutenzalutamide Soft Capsules Average Price by Sales Channels (2021-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World Deutenzalutamide Soft Capsules Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Metastatic Castration-Resistant Prostate Cancer
9.2.2 Non-Metastatic Castration-Resistant Prostate Cancer
9.2.3 Metastatic Hormone-Sensitive Prostate Cancer
9.2.4 Others
9.3 Market Segment by Application
9.3.1 World Deutenzalutamide Soft Capsules Production by Application (2021-2032)
9.3.2 World Deutenzalutamide Soft Capsules Production Value by Application (2021-2032)
9.3.3 World Deutenzalutamide Soft Capsules Average Price by Application (2021-2032)
10 COMPANY PROFILES
10.1 Hinovapharma
10.1.1 Hinovapharma Details
10.1.2 Hinovapharma Major Business
10.1.3 Hinovapharma Deutenzalutamide Soft Capsules Product and Services
10.1.4 Hinovapharma Deutenzalutamide Soft Capsules Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.1.5 Hinovapharma Recent Developments/Updates
10.1.6 Hinovapharma Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 Deutenzalutamide Soft Capsules Industry Chain
11.2 Deutenzalutamide Soft Capsules Upstream Analysis
11.2.1 Deutenzalutamide Soft Capsules Core Raw Materials
11.2.2 Main Manufacturers of Deutenzalutamide Soft Capsules Core Raw Materials
11.3 Midstream Analysis
11.4 Downstream Analysis
11.5 Deutenzalutamide Soft Capsules Production Mode
11.6 Deutenzalutamide Soft Capsules Procurement Model
11.7 Deutenzalutamide Soft Capsules Industry Sales Model and Sales Channels
11.7.1 Deutenzalutamide Soft Capsules Sales Model
11.7.2 Deutenzalutamide Soft Capsules Typical Distributors
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
LIST OF TABLES
Table 1. World Deutenzalutamide Soft Capsules Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Deutenzalutamide Soft Capsules Production Value by Region (2021-2026) & (USD Million)
Table 3. World Deutenzalutamide Soft Capsules Production Value by Region (2027-2032) & (USD Million)
Table 4. World Deutenzalutamide Soft Capsules Production Value Market Share by Region (2021-2026)
Table 5. World Deutenzalutamide Soft Capsules Production Value Market Share by Region (2027-2032)
Table 6. World Deutenzalutamide Soft Capsules Production by Region (2021-2026) & (Units)
Table 7. World Deutenzalutamide Soft Capsules Production by Region (2027-2032) & (Units)
Table 8. World Deutenzalutamide Soft Capsules Production Market Share by Region (2021-2026)
Table 9. World Deutenzalutamide Soft Capsules Production Market Share by Region (2027-2032)
Table 10. World Deutenzalutamide Soft Capsules Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Deutenzalutamide Soft Capsules Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Deutenzalutamide Soft Capsules Major Market Trends
Table 13. World Deutenzalutamide Soft Capsules Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World Deutenzalutamide Soft Capsules Consumption by Region (2021-2026) & (Units)
Table 15. World Deutenzalutamide Soft Capsules Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World Deutenzalutamide Soft Capsules Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Deutenzalutamide Soft Capsules Producers in 2025
Table 18. World Deutenzalutamide Soft Capsules Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key Deutenzalutamide Soft Capsules Producers in 2025
Table 20. World Deutenzalutamide Soft Capsules Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Deutenzalutamide Soft Capsules Company Evaluation Quadrant
Table 22. World Deutenzalutamide Soft Capsules Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Deutenzalutamide Soft Capsules Production Site of Key Manufacturer
Table 24. Deutenzalutamide Soft Capsules Market: Company Product Type Footprint
Table 25. Deutenzalutamide Soft Capsules Market: Company Product Application Footprint
Table 26. Deutenzalutamide Soft Capsules Competitive Factors
Table 27. Deutenzalutamide Soft Capsules New Entrant and Capacity Expansion Plans
Table 28. Deutenzalutamide Soft Capsules Mergers & Acquisitions Activity
Table 29. United States VS China Deutenzalutamide Soft Capsules Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Deutenzalutamide Soft Capsules Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China Deutenzalutamide Soft Capsules Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based Deutenzalutamide Soft Capsules Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Deutenzalutamide Soft Capsules Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Deutenzalutamide Soft Capsules Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Deutenzalutamide Soft Capsules Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers Deutenzalutamide Soft Capsules Production Market Share (2021-2026)
Table 37. China Based Deutenzalutamide Soft Capsules Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Deutenzalutamide Soft Capsules Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Deutenzalutamide Soft Capsules Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Deutenzalutamide Soft Capsules Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers Deutenzalutamide Soft Capsules Production Market Share (2021-2026)
Table 42. Rest of World Based Deutenzalutamide Soft Capsules Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Deutenzalutamide Soft Capsules Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Deutenzalutamide Soft Capsules Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Deutenzalutamide Soft Capsules Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers Deutenzalutamide Soft Capsules Production Market Share (2021-2026)
Table 47. World Deutenzalutamide Soft Capsules Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Deutenzalutamide Soft Capsules Production by Type (2021-2026) & (Units)
Table 49. World Deutenzalutamide Soft Capsules Production by Type (2027-2032) & (Units)
Table 50. World Deutenzalutamide Soft Capsules Production Value by Type (2021-2026) & (USD Million)
Table 51. World Deutenzalutamide Soft Capsules Production Value by Type (2027-2032) & (USD Million)
Table 52. World Deutenzalutamide Soft Capsules Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Deutenzalutamide Soft Capsules Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Deutenzalutamide Soft Capsules Production Value by Combined medication, (USD Million), 2021 & 2025 & 2032
Table 55. World Deutenzalutamide Soft Capsules Production by Combined medication (2021-2026) & (Units)
Table 56. World Deutenzalutamide Soft Capsules Production by Combined medication (2027-2032) & (Units)
Table 57. World Deutenzalutamide Soft Capsules Production Value by Combined medication (2021-2026) & (USD Million)
Table 58. World Deutenzalutamide Soft Capsules Production Value by Combined medication (2027-2032) & (USD Million)
Table 59. World Deutenzalutamide Soft Capsules Average Price by Combined medication (2021-2026) & (US$/Unit)
Table 60. World Deutenzalutamide Soft Capsules Average Price by Combined medication (2027-2032) & (US$/Unit)
Table 61. World Deutenzalutamide Soft Capsules Production Value by Production Technology, (USD Million), 2021 & 2025 & 2032
Table 62. World Deutenzalutamide Soft Capsules Production by Production Technology (2021-2026) & (Units)
Table 63. World Deutenzalutamide Soft Capsules Production by Production Technology (2027-2032) & (Units)
Table 64. World Deutenzalutamide Soft Capsules Production Value by Production Technology (2021-2026) & (USD Million)
Table 65. World Deutenzalutamide Soft Capsules Production Value by Production Technology (2027-2032) & (USD Million)
Table 66. World Deutenzalutamide Soft Capsules Average Price by Production Technology (2021-2026) & (US$/Unit)
Table 67. World Deutenzalutamide Soft Capsules Average Price by Production Technology (2027-2032) & (US$/Unit)
Table 68. World Deutenzalutamide Soft Capsules Production Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Table 69. World Deutenzalutamide Soft Capsules Production by Sales Channels (2021-2026) & (Units)
Table 70. World Deutenzalutamide Soft Capsules Production by Sales Channels (2027-2032) & (Units)
Table 71. World Deutenzalutamide Soft Capsules Production Value by Sales Channels (2021-2026) & (USD Million)
Table 72. World Deutenzalutamide Soft Capsules Production Value by Sales Channels (2027-2032) & (USD Million)
Table 73. World Deutenzalutamide Soft Capsules Average Price by Sales Channels (2021-2026) & (US$/Unit)
Table 74. World Deutenzalutamide Soft Capsules Average Price by Sales Channels (2027-2032) & (US$/Unit)
Table 75. World Deutenzalutamide Soft Capsules Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 76. World Deutenzalutamide Soft Capsules Production by Application (2021-2026) & (Units)
Table 77. World Deutenzalutamide Soft Capsules Production by Application (2027-2032) & (Units)
Table 78. World Deutenzalutamide Soft Capsules Production Value by Application (2021-2026) & (USD Million)
Table 79. World Deutenzalutamide Soft Capsules Production Value by Application (2027-2032) & (USD Million)
Table 80. World Deutenzalutamide Soft Capsules Average Price by Application (2021-2026) & (US$/Unit)
Table 81. World Deutenzalutamide Soft Capsules Average Price by Application (2027-2032) & (US$/Unit)
Table 82. Hinovapharma Basic Information, Manufacturing Base and Competitors
Table 83. Hinovapharma Major Business
Table 84. Hinovapharma Deutenzalutamide Soft Capsules Product and Services
Table 85. Hinovapharma Deutenzalutamide Soft Capsules Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 86. Hinovapharma Recent Developments/Updates
Table 87. Hinovapharma Competitive Strengths & Weaknesses
Table 88. Global Key Players of Deutenzalutamide Soft Capsules Upstream (Raw Materials)
Table 89. Global Deutenzalutamide Soft Capsules Typical Customers
Table 90. Deutenzalutamide Soft Capsules Typical Distributors
Table 1. World Deutenzalutamide Soft Capsules Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Deutenzalutamide Soft Capsules Production Value by Region (2021-2026) & (USD Million)
Table 3. World Deutenzalutamide Soft Capsules Production Value by Region (2027-2032) & (USD Million)
Table 4. World Deutenzalutamide Soft Capsules Production Value Market Share by Region (2021-2026)
Table 5. World Deutenzalutamide Soft Capsules Production Value Market Share by Region (2027-2032)
Table 6. World Deutenzalutamide Soft Capsules Production by Region (2021-2026) & (Units)
Table 7. World Deutenzalutamide Soft Capsules Production by Region (2027-2032) & (Units)
Table 8. World Deutenzalutamide Soft Capsules Production Market Share by Region (2021-2026)
Table 9. World Deutenzalutamide Soft Capsules Production Market Share by Region (2027-2032)
Table 10. World Deutenzalutamide Soft Capsules Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Deutenzalutamide Soft Capsules Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Deutenzalutamide Soft Capsules Major Market Trends
Table 13. World Deutenzalutamide Soft Capsules Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World Deutenzalutamide Soft Capsules Consumption by Region (2021-2026) & (Units)
Table 15. World Deutenzalutamide Soft Capsules Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World Deutenzalutamide Soft Capsules Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Deutenzalutamide Soft Capsules Producers in 2025
Table 18. World Deutenzalutamide Soft Capsules Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key Deutenzalutamide Soft Capsules Producers in 2025
Table 20. World Deutenzalutamide Soft Capsules Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Deutenzalutamide Soft Capsules Company Evaluation Quadrant
Table 22. World Deutenzalutamide Soft Capsules Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Deutenzalutamide Soft Capsules Production Site of Key Manufacturer
Table 24. Deutenzalutamide Soft Capsules Market: Company Product Type Footprint
Table 25. Deutenzalutamide Soft Capsules Market: Company Product Application Footprint
Table 26. Deutenzalutamide Soft Capsules Competitive Factors
Table 27. Deutenzalutamide Soft Capsules New Entrant and Capacity Expansion Plans
Table 28. Deutenzalutamide Soft Capsules Mergers & Acquisitions Activity
Table 29. United States VS China Deutenzalutamide Soft Capsules Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Deutenzalutamide Soft Capsules Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China Deutenzalutamide Soft Capsules Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based Deutenzalutamide Soft Capsules Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Deutenzalutamide Soft Capsules Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Deutenzalutamide Soft Capsules Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Deutenzalutamide Soft Capsules Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers Deutenzalutamide Soft Capsules Production Market Share (2021-2026)
Table 37. China Based Deutenzalutamide Soft Capsules Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Deutenzalutamide Soft Capsules Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Deutenzalutamide Soft Capsules Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Deutenzalutamide Soft Capsules Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers Deutenzalutamide Soft Capsules Production Market Share (2021-2026)
Table 42. Rest of World Based Deutenzalutamide Soft Capsules Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Deutenzalutamide Soft Capsules Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Deutenzalutamide Soft Capsules Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Deutenzalutamide Soft Capsules Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers Deutenzalutamide Soft Capsules Production Market Share (2021-2026)
Table 47. World Deutenzalutamide Soft Capsules Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Deutenzalutamide Soft Capsules Production by Type (2021-2026) & (Units)
Table 49. World Deutenzalutamide Soft Capsules Production by Type (2027-2032) & (Units)
Table 50. World Deutenzalutamide Soft Capsules Production Value by Type (2021-2026) & (USD Million)
Table 51. World Deutenzalutamide Soft Capsules Production Value by Type (2027-2032) & (USD Million)
Table 52. World Deutenzalutamide Soft Capsules Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Deutenzalutamide Soft Capsules Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Deutenzalutamide Soft Capsules Production Value by Combined medication, (USD Million), 2021 & 2025 & 2032
Table 55. World Deutenzalutamide Soft Capsules Production by Combined medication (2021-2026) & (Units)
Table 56. World Deutenzalutamide Soft Capsules Production by Combined medication (2027-2032) & (Units)
Table 57. World Deutenzalutamide Soft Capsules Production Value by Combined medication (2021-2026) & (USD Million)
Table 58. World Deutenzalutamide Soft Capsules Production Value by Combined medication (2027-2032) & (USD Million)
Table 59. World Deutenzalutamide Soft Capsules Average Price by Combined medication (2021-2026) & (US$/Unit)
Table 60. World Deutenzalutamide Soft Capsules Average Price by Combined medication (2027-2032) & (US$/Unit)
Table 61. World Deutenzalutamide Soft Capsules Production Value by Production Technology, (USD Million), 2021 & 2025 & 2032
Table 62. World Deutenzalutamide Soft Capsules Production by Production Technology (2021-2026) & (Units)
Table 63. World Deutenzalutamide Soft Capsules Production by Production Technology (2027-2032) & (Units)
Table 64. World Deutenzalutamide Soft Capsules Production Value by Production Technology (2021-2026) & (USD Million)
Table 65. World Deutenzalutamide Soft Capsules Production Value by Production Technology (2027-2032) & (USD Million)
Table 66. World Deutenzalutamide Soft Capsules Average Price by Production Technology (2021-2026) & (US$/Unit)
Table 67. World Deutenzalutamide Soft Capsules Average Price by Production Technology (2027-2032) & (US$/Unit)
Table 68. World Deutenzalutamide Soft Capsules Production Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Table 69. World Deutenzalutamide Soft Capsules Production by Sales Channels (2021-2026) & (Units)
Table 70. World Deutenzalutamide Soft Capsules Production by Sales Channels (2027-2032) & (Units)
Table 71. World Deutenzalutamide Soft Capsules Production Value by Sales Channels (2021-2026) & (USD Million)
Table 72. World Deutenzalutamide Soft Capsules Production Value by Sales Channels (2027-2032) & (USD Million)
Table 73. World Deutenzalutamide Soft Capsules Average Price by Sales Channels (2021-2026) & (US$/Unit)
Table 74. World Deutenzalutamide Soft Capsules Average Price by Sales Channels (2027-2032) & (US$/Unit)
Table 75. World Deutenzalutamide Soft Capsules Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 76. World Deutenzalutamide Soft Capsules Production by Application (2021-2026) & (Units)
Table 77. World Deutenzalutamide Soft Capsules Production by Application (2027-2032) & (Units)
Table 78. World Deutenzalutamide Soft Capsules Production Value by Application (2021-2026) & (USD Million)
Table 79. World Deutenzalutamide Soft Capsules Production Value by Application (2027-2032) & (USD Million)
Table 80. World Deutenzalutamide Soft Capsules Average Price by Application (2021-2026) & (US$/Unit)
Table 81. World Deutenzalutamide Soft Capsules Average Price by Application (2027-2032) & (US$/Unit)
Table 82. Hinovapharma Basic Information, Manufacturing Base and Competitors
Table 83. Hinovapharma Major Business
Table 84. Hinovapharma Deutenzalutamide Soft Capsules Product and Services
Table 85. Hinovapharma Deutenzalutamide Soft Capsules Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 86. Hinovapharma Recent Developments/Updates
Table 87. Hinovapharma Competitive Strengths & Weaknesses
Table 88. Global Key Players of Deutenzalutamide Soft Capsules Upstream (Raw Materials)
Table 89. Global Deutenzalutamide Soft Capsules Typical Customers
Table 90. Deutenzalutamide Soft Capsules Typical Distributors
LIST OF FIGURES
Figure 1. Deutenzalutamide Soft Capsules Picture
Figure 2. World Deutenzalutamide Soft Capsules Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Deutenzalutamide Soft Capsules Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Deutenzalutamide Soft Capsules Production (2021-2032) & (Units)
Figure 5. World Deutenzalutamide Soft Capsules Average Price (2021-2032) & (US$/Unit)
Figure 6. World Deutenzalutamide Soft Capsules Production Value Market Share by Region (2021-2032)
Figure 7. World Deutenzalutamide Soft Capsules Production Market Share by Region (2021-2032)
Figure 8. China Deutenzalutamide Soft Capsules Production (2021-2032) & (Units)
Figure 9. Deutenzalutamide Soft Capsules Market Drivers
Figure 10. Factors Affecting Demand
Figure 11. World Deutenzalutamide Soft Capsules Consumption (2021-2032) & (Units)
Figure 12. World Deutenzalutamide Soft Capsules Consumption Market Share by Region (2021-2032)
Figure 13. United States Deutenzalutamide Soft Capsules Consumption (2021-2032) & (Units)
Figure 14. China Deutenzalutamide Soft Capsules Consumption (2021-2032) & (Units)
Figure 15. Europe Deutenzalutamide Soft Capsules Consumption (2021-2032) & (Units)
Figure 16. Japan Deutenzalutamide Soft Capsules Consumption (2021-2032) & (Units)
Figure 17. South Korea Deutenzalutamide Soft Capsules Consumption (2021-2032) & (Units)
Figure 18. ASEAN Deutenzalutamide Soft Capsules Consumption (2021-2032) & (Units)
Figure 19. India Deutenzalutamide Soft Capsules Consumption (2021-2032) & (Units)
Figure 20. Producer Shipments of Deutenzalutamide Soft Capsules by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 21. Global Four-firm Concentration Ratios (CR4) for Deutenzalutamide Soft Capsules Markets in 2025
Figure 22. Global Four-firm Concentration Ratios (CR8) for Deutenzalutamide Soft Capsules Markets in 2025
Figure 23. United States VS China: Deutenzalutamide Soft Capsules Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 24. United States VS China: Deutenzalutamide Soft Capsules Production Market Share Comparison (2021 & 2025 & 2032)
Figure 25. United States VS China: Deutenzalutamide Soft Capsules Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 26. United States Based Manufacturers Deutenzalutamide Soft Capsules Production Market Share 2025
Figure 27. China Based Manufacturers Deutenzalutamide Soft Capsules Production Market Share 2025
Figure 28. Rest of World Based Manufacturers Deutenzalutamide Soft Capsules Production Market Share 2025
Figure 29. World Deutenzalutamide Soft Capsules Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Deutenzalutamide Soft Capsules Production Value Market Share by Type in 2025
Figure 31. 28 Capsules Per Box
Figure 32. 112 Capsules Per Bottle
Figure 33. World Deutenzalutamide Soft Capsules Production Market Share by Type (2021-2032)
Figure 34. World Deutenzalutamide Soft Capsules Production Value Market Share by Type (2021-2032)
Figure 35. World Deutenzalutamide Soft Capsules Average Price by Type (2021-2032) & (US$/Unit)
Figure 36. World Deutenzalutamide Soft Capsules Production Value by Combined medication, (USD Million), 2021 & 2025 & 2032
Figure 37. World Deutenzalutamide Soft Capsules Production Value Market Share by Combined medication in 2025
Figure 38. Deuteroenzalutamide in combination with Androgen Synthesis Inhibitors
Figure 39. Deuteroenzalutamide in combination with Hormonal Antineoplastic Drugs
Figure 40. World Deutenzalutamide Soft Capsules Production Market Share by Combined medication (2021-2032)
Figure 41. World Deutenzalutamide Soft Capsules Production Value Market Share by Combined medication (2021-2032)
Figure 42. World Deutenzalutamide Soft Capsules Average Price by Combined medication (2021-2032) & (US$/Unit)
Figure 43. World Deutenzalutamide Soft Capsules Production Value by Production Technology, (USD Million), 2021 & 2025 & 2032
Figure 44. World Deutenzalutamide Soft Capsules Production Value Market Share by Production Technology in 2025
Figure 45. Innovator
Figure 46. Generic
Figure 47. World Deutenzalutamide Soft Capsules Production Market Share by Production Technology (2021-2032)
Figure 48. World Deutenzalutamide Soft Capsules Production Value Market Share by Production Technology (2021-2032)
Figure 49. World Deutenzalutamide Soft Capsules Average Price by Production Technology (2021-2032) & (US$/Unit)
Figure 50. World Deutenzalutamide Soft Capsules Production Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Figure 51. World Deutenzalutamide Soft Capsules Production Value Market Share by Sales Channels in 2025
Figure 52. Hospital
Figure 53. Retail
Figure 54. Online
Figure 55. World Deutenzalutamide Soft Capsules Production Market Share by Sales Channels (2021-2032)
Figure 56. World Deutenzalutamide Soft Capsules Production Value Market Share by Sales Channels (2021-2032)
Figure 57. World Deutenzalutamide Soft Capsules Average Price by Sales Channels (2021-2032) & (US$/Unit)
Figure 58. World Deutenzalutamide Soft Capsules Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 59. World Deutenzalutamide Soft Capsules Production Value Market Share by Application in 2025
Figure 60. Metastatic Castration-Resistant Prostate Cancer
Figure 61. Non-Metastatic Castration-Resistant Prostate Cancer
Figure 62. Metastatic Hormone-Sensitive Prostate Cancer
Figure 63. Others
Figure 64. World Deutenzalutamide Soft Capsules Production Market Share by Application (2021-2032)
Figure 65. World Deutenzalutamide Soft Capsules Production Value Market Share by Application (2021-2032)
Figure 66. World Deutenzalutamide Soft Capsules Average Price by Application (2021-2032) & (US$/Unit)
Figure 67. Deutenzalutamide Soft Capsules Industry Chain
Figure 68. Deutenzalutamide Soft Capsules Procurement Model
Figure 69. Deutenzalutamide Soft Capsules Sales Model
Figure 70. Deutenzalutamide Soft Capsules Sales Channels, Direct Sales, and Distribution
Figure 71. Methodology
Figure 72. Research Process and Data Source
Figure 1. Deutenzalutamide Soft Capsules Picture
Figure 2. World Deutenzalutamide Soft Capsules Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Deutenzalutamide Soft Capsules Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Deutenzalutamide Soft Capsules Production (2021-2032) & (Units)
Figure 5. World Deutenzalutamide Soft Capsules Average Price (2021-2032) & (US$/Unit)
Figure 6. World Deutenzalutamide Soft Capsules Production Value Market Share by Region (2021-2032)
Figure 7. World Deutenzalutamide Soft Capsules Production Market Share by Region (2021-2032)
Figure 8. China Deutenzalutamide Soft Capsules Production (2021-2032) & (Units)
Figure 9. Deutenzalutamide Soft Capsules Market Drivers
Figure 10. Factors Affecting Demand
Figure 11. World Deutenzalutamide Soft Capsules Consumption (2021-2032) & (Units)
Figure 12. World Deutenzalutamide Soft Capsules Consumption Market Share by Region (2021-2032)
Figure 13. United States Deutenzalutamide Soft Capsules Consumption (2021-2032) & (Units)
Figure 14. China Deutenzalutamide Soft Capsules Consumption (2021-2032) & (Units)
Figure 15. Europe Deutenzalutamide Soft Capsules Consumption (2021-2032) & (Units)
Figure 16. Japan Deutenzalutamide Soft Capsules Consumption (2021-2032) & (Units)
Figure 17. South Korea Deutenzalutamide Soft Capsules Consumption (2021-2032) & (Units)
Figure 18. ASEAN Deutenzalutamide Soft Capsules Consumption (2021-2032) & (Units)
Figure 19. India Deutenzalutamide Soft Capsules Consumption (2021-2032) & (Units)
Figure 20. Producer Shipments of Deutenzalutamide Soft Capsules by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 21. Global Four-firm Concentration Ratios (CR4) for Deutenzalutamide Soft Capsules Markets in 2025
Figure 22. Global Four-firm Concentration Ratios (CR8) for Deutenzalutamide Soft Capsules Markets in 2025
Figure 23. United States VS China: Deutenzalutamide Soft Capsules Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 24. United States VS China: Deutenzalutamide Soft Capsules Production Market Share Comparison (2021 & 2025 & 2032)
Figure 25. United States VS China: Deutenzalutamide Soft Capsules Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 26. United States Based Manufacturers Deutenzalutamide Soft Capsules Production Market Share 2025
Figure 27. China Based Manufacturers Deutenzalutamide Soft Capsules Production Market Share 2025
Figure 28. Rest of World Based Manufacturers Deutenzalutamide Soft Capsules Production Market Share 2025
Figure 29. World Deutenzalutamide Soft Capsules Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Deutenzalutamide Soft Capsules Production Value Market Share by Type in 2025
Figure 31. 28 Capsules Per Box
Figure 32. 112 Capsules Per Bottle
Figure 33. World Deutenzalutamide Soft Capsules Production Market Share by Type (2021-2032)
Figure 34. World Deutenzalutamide Soft Capsules Production Value Market Share by Type (2021-2032)
Figure 35. World Deutenzalutamide Soft Capsules Average Price by Type (2021-2032) & (US$/Unit)
Figure 36. World Deutenzalutamide Soft Capsules Production Value by Combined medication, (USD Million), 2021 & 2025 & 2032
Figure 37. World Deutenzalutamide Soft Capsules Production Value Market Share by Combined medication in 2025
Figure 38. Deuteroenzalutamide in combination with Androgen Synthesis Inhibitors
Figure 39. Deuteroenzalutamide in combination with Hormonal Antineoplastic Drugs
Figure 40. World Deutenzalutamide Soft Capsules Production Market Share by Combined medication (2021-2032)
Figure 41. World Deutenzalutamide Soft Capsules Production Value Market Share by Combined medication (2021-2032)
Figure 42. World Deutenzalutamide Soft Capsules Average Price by Combined medication (2021-2032) & (US$/Unit)
Figure 43. World Deutenzalutamide Soft Capsules Production Value by Production Technology, (USD Million), 2021 & 2025 & 2032
Figure 44. World Deutenzalutamide Soft Capsules Production Value Market Share by Production Technology in 2025
Figure 45. Innovator
Figure 46. Generic
Figure 47. World Deutenzalutamide Soft Capsules Production Market Share by Production Technology (2021-2032)
Figure 48. World Deutenzalutamide Soft Capsules Production Value Market Share by Production Technology (2021-2032)
Figure 49. World Deutenzalutamide Soft Capsules Average Price by Production Technology (2021-2032) & (US$/Unit)
Figure 50. World Deutenzalutamide Soft Capsules Production Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Figure 51. World Deutenzalutamide Soft Capsules Production Value Market Share by Sales Channels in 2025
Figure 52. Hospital
Figure 53. Retail
Figure 54. Online
Figure 55. World Deutenzalutamide Soft Capsules Production Market Share by Sales Channels (2021-2032)
Figure 56. World Deutenzalutamide Soft Capsules Production Value Market Share by Sales Channels (2021-2032)
Figure 57. World Deutenzalutamide Soft Capsules Average Price by Sales Channels (2021-2032) & (US$/Unit)
Figure 58. World Deutenzalutamide Soft Capsules Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 59. World Deutenzalutamide Soft Capsules Production Value Market Share by Application in 2025
Figure 60. Metastatic Castration-Resistant Prostate Cancer
Figure 61. Non-Metastatic Castration-Resistant Prostate Cancer
Figure 62. Metastatic Hormone-Sensitive Prostate Cancer
Figure 63. Others
Figure 64. World Deutenzalutamide Soft Capsules Production Market Share by Application (2021-2032)
Figure 65. World Deutenzalutamide Soft Capsules Production Value Market Share by Application (2021-2032)
Figure 66. World Deutenzalutamide Soft Capsules Average Price by Application (2021-2032) & (US$/Unit)
Figure 67. Deutenzalutamide Soft Capsules Industry Chain
Figure 68. Deutenzalutamide Soft Capsules Procurement Model
Figure 69. Deutenzalutamide Soft Capsules Sales Model
Figure 70. Deutenzalutamide Soft Capsules Sales Channels, Direct Sales, and Distribution
Figure 71. Methodology
Figure 72. Research Process and Data Source
